youtube_live
Q3 2026 earnings • released • EPS beat +११.३८% • Revenue beat +७.३३%
See resultschevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३१.३८
arrow_upward
+६.७०%(+१.९७) 1D
US$ ३१.९८
arrow_upward
+१.९१% (+०.६०)bedtimeAfter hours
Closed: नोभेम्बर ९, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.३२
High
US$ ३१.४४
Low
US$ २८.९३
Mkt. cap
१.८७ अरब
Avg. vol.
१२.९३ लाख
Volume
६.००
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.३२
High
US$ ३१.४४
Low
US$ २८.९३
Mkt. cap
१.८७ अरब
Avg. vol.
१२.९३ लाख
Volume
६.००
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
CNBC
·
५७ मिनेट पहिले
Anthropic sets price range of $70 to $78 in upcoming IPO as AI lab marches towards Nasdaq
The Motley Fool
·
३२ मिनेट पहिले
Nasdaq-100 Correction: 2 Proven Winners That Can Buck Historic Volatility
24/7 Wall St.
·
२२ मिनेट पहिले
The Nasdaq-100 Just Had Its Best Day Since March Without Nvidia’s Help
Bloomberg.com
·
१ घण्टा पहिले
Asian Stocks to Rally on US Tech Surge, Oil Slump: Markets Wrap
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc